Top 10 Biopharma M&A Deals in Q1 2024

The 10 biggest biopharma deals of Q1 '24 were worth ~$17 billion. Here's a look at key trends behind them:

April 23, 2024

Top 15 Oncology Drugs by Sales in 2023

Oncology is the single largest market in the global biopharma industry, worth over $200B. Here's a look at the top 15 drugs in the space, and some insights behind the numbers:

April 15, 2024

Top 10 Immunology Drugs by Worldwide Sales in 2023

The top 10 immunology drugs generated more than $70 billion in revenue. last year. Here are some surprising trends behind the second biggest market in biopharma

April 13, 2024

Top 15 Drugs by Worldwide Sales in 2023

The list of the world's 15 top selling drugs in 2023 is led by Merck's oncology powerhouse Keytruda, which achieved a record of $25 billion in revenue last year.

March 22, 2024

Race for GLP-1 Obesity Drugs Heats Up

13 years after Roche halted its GLP-1 drug trials due to side effects, it's making a $3.1B acquisition to get back in the weight loss game.

January 20, 2024

How Drug Pricing in the US Compares to Other Countries

New weight loss drugs like Ozempic, Wegovy and Zepbound have been on fire - but how does pricing in the US compare to other countries? It’s no secret that drugs cost more in the US than in other developed economies, and the Inflation Reduction Act’s provision to allow Medicare to negotiate drug prices has reignited that debate.

January 20, 2024

AI Drug Discovery Continues to Show Strength, but Some Win More Than Others

While AI drug discovery has huge promise, achieving the biggest wins involves not just the best models, but old-fashioned persistence and risk taking.

January 20, 2024

Big Pharma Partnerships in 2023: A Comprehensive Overview

Facing a landscape where many blockbuster drugs are nearing or have reached the end of their exclusivity, large biopharma leaders are increasingly turning to collaborations to refill their pipelines with promising therapeutics.

January 19, 2024